Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lu Yang

13PUBLICATIONS

6CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Mar 21, 2025

Progression-Free Survival Prediction Model Based on AI-Enhanced Dynamic Radiomics for Personalized EGFR-TKI Treatment Monitoring Patients With Lung Adenocarcinoma.

Yan'e Liu, Xiangfeng Luo, Lu Yang

|Sep 19, 2023

The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study.

Shuyang Zhang, Lu Yang, Yaning Yang

|Oct 24, 2022

An exploration of LAF-bTMB as a predictor for the efficacy of immunotherapy combined with chemotherapy in non-small cell lung cancer.

Shuyang Zhang, Lu Yang, Yaning Yang

|Oct 11, 2022

Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice.

Yaning Yang, Xin Ai, Haiyan Xu

|Oct 06, 2021

Possibility of brigatinib-based therapy, or chemotherapy plus anti-angiogenic treatment after resistance of osimertinib harboring EGFR T790M-cis-C797S mutations in lung adenocarcinoma patients.

Yaning Yang, Haiyan Xu, Li Ma

|Aug 31, 2021

Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.

Shuyang Zhang, Huihui Yin, Jing Zhang

Pageof 3

Frequent Collaborators

10 joint publications

Yan Wang

6 joint publications

Haiyan Xu

2 joint publications

Di Ma

1 joint publications

Fei Xu

1 joint publications

Yaning Yang

1 joint publications

Yan'e Liu

Frequent Collaborators

10 joint publications

Yan Wang

6 joint publications

Haiyan Xu

2 joint publications

Di Ma

1 joint publications

Fei Xu

Top Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on : Oct 10, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on : Oct 10, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos